Citron Research, the firm led by short-seller Andrew Left, unpacked its bear case for Palantir, using OpenAI to show why it ...

Short-seller Citron targets PLTR again, using a Databricks comparison to argue the stock is overvalued after its report sent ...

Palantir Technologies Inc (NASDAQ:PLTR) shares are trading lower Wednesday as the stock continues to pull back following a ...

Short-seller Andrew Left is betting against Palantir amid a stunning 144% rally in the shares in 2025. Left says the ...

Shares of Palantir (PLTR) dropped over 9% on Tuesday due to a critical report from short-selling firm Citron Research, which ...

Andrew Left argues that investors have overhyped Palantir stock, and its valuation pales in comparison to a true AI leader ...

Palantir shares tumbled Tuesday afternoon, extending recent losses as a high-profile short seller fueled worries the stock ...

Andrew Left of Citron Research, which rose to fame for their role in exposing Valeant Pharmaceuticals, has taken to X to voice his concerns over the ruling in the Trump trial. Using Citron ...

Citron Reseach’s founder Andrew Left, who once said crypto is “complete fraud,” is now facing fraud charges after the SEC accused him of profiting $16 million from market manipulation.

Left's other company, Citron Research, on May 17, 2019, issued a negative tweet on Beyond Meat, which recommended that readers sell the stock and assign it a target price of $65 per share, at a ...